Homocysteine in retinal artery occlusive disease: A meta-analysis of cohort studies
- PMID: 29146987
- PMCID: PMC5691205
- DOI: 10.1038/s41598-017-16065-2
Homocysteine in retinal artery occlusive disease: A meta-analysis of cohort studies
Abstract
Few studies have reported the relationship between retinal artery occlusion (RAO) and plasma homocysteine (Hcy) levels. Our goal was to evaluate the association between the plasma Hcy level and the risk of RAO disease. Several databases were searched for all published studies that involved Hcy and RAO. Six studies evaluated hyperhomocysteinemia (hHcy) in retinal artery occlusion patients and controls; the incidence of hHcy in patients with RAO was higher than the control and the pooled odds ratio (OR) was 6.64 (95% confidence interval (CI): 3.42, 12.89). Subgroup analyses showed that the ORs were 4.77 (95% CI: 2.69, 8.46) in Western countries, 22.19 (95% CI: 2.46, 200.37) in Asian countries, 9.70 (95% CI: 4.43, 21.20) in the age matched group, 11.41 (95% CI: 3.32, 39.18) in the sex matched group, 9.70 (95% CI: 4.37, 21.53) in the healthy control group, and 6.82 (95% CI: 4.19, 11.10) in the sample size >30. The mean plasma Hcy level from 5 case-control studies was higher than controls, and the weighted mean difference (WMD) was 6.54 (95% CI: 2.79, 10.29). Retinal artery occlusion is associated with elevated plasma Hcy levels. Our study results suggest that hHcy is probably an independent risk factor for RAO.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Hyperhomocysteinemia and retinal vascular occlusive disease.Eur J Ophthalmol. 2002 Nov-Dec;12(6):495-500. doi: 10.1177/112067210201200608. Eur J Ophthalmol. 2002. PMID: 12510718
-
The role of hyperhomocysteinemia and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with retinal artery occlusion.Am J Ophthalmol. 2002 Jul;134(1):57-61. doi: 10.1016/s0002-9394(02)01471-x. Am J Ophthalmol. 2002. PMID: 12095808
-
Plasma homocysteine and retinal artery occlusive disease: a case-control study.Ann Saudi Med. 2004 May-Jun;24(3):186-8. doi: 10.5144/0256-4947.2004.186. Ann Saudi Med. 2004. PMID: 15307456 Free PMC article.
-
Association of homocysteine level with risk of stroke: A dose-response meta-analysis of prospective cohort studies.Nutr Metab Cardiovasc Dis. 2020 Oct 30;30(11):1861-1869. doi: 10.1016/j.numecd.2020.07.026. Epub 2020 Jul 24. Nutr Metab Cardiovasc Dis. 2020. PMID: 32912796
-
Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.J Cardiovasc Surg (Torino). 2007 Oct;48(5):601-5. J Cardiovasc Surg (Torino). 2007. PMID: 17989630 Review.
Cited by
-
Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person.EPMA J. 2021 Nov 11;12(4):477-505. doi: 10.1007/s13167-021-00263-0. eCollection 2021 Dec. EPMA J. 2021. PMID: 34786033 Free PMC article. Review.
-
Hydrogen sulfide intervention in cystathionine-β-synthase mutant mouse helps restore ocular homeostasis.Int J Ophthalmol. 2019 May 18;12(5):754-764. doi: 10.18240/ijo.2019.05.09. eCollection 2019. Int J Ophthalmol. 2019. PMID: 31131233 Free PMC article.
-
Hyperhomocysteinemia in Adult Patients: A Treatable Metabolic Condition.Nutrients. 2023 Dec 30;16(1):135. doi: 10.3390/nu16010135. Nutrients. 2023. PMID: 38201964 Free PMC article. Review.
-
Central Retinal Artery Occlusion Is Related to Vascular Endothelial Injury and Left Ventricular Diastolic Dysfunction.J Clin Med. 2022 Apr 18;11(8):2263. doi: 10.3390/jcm11082263. J Clin Med. 2022. PMID: 35456355 Free PMC article.
-
Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.Biomolecules. 2020 Jul 29;10(8):1119. doi: 10.3390/biom10081119. Biomolecules. 2020. PMID: 32751132 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources